133 related articles for article (PubMed ID: 28842140)
1. Blastic Transformation in Mexican Population With Chronic Myelomonocytic Leukemia.
Rivera Duarte A; Armengol Alonso A; Sandoval Cartagena E; Tuna Aguilar E
Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):532-538. PubMed ID: 28842140
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia.
Courville EL; Wu Y; Kourda J; Roth CG; Brockmann J; Muzikansky A; Fathi AT; de Leval L; Orazi A; Hasserjian RP
Mod Pathol; 2013 Jun; 26(6):751-61. PubMed ID: 23307061
[TBL] [Abstract][Full Text] [Related]
3. [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].
Germing U; Strupp C; Meckenstock G; Giagounidis A; Minning H; Aul C
Med Klin (Munich); 1999 Sep; 94(9):467-72. PubMed ID: 10544608
[TBL] [Abstract][Full Text] [Related]
4. Pleural effusion heralds acute leukemic transformation of chronic myelomonocytic leukemia.
Huang CT; Kuo PH; Yao M; Tsai YJ; Yang PC
South Med J; 2008 Dec; 101(12):1279-80. PubMed ID: 19005440
[No Abstract] [Full Text] [Related]
5. Clinical importance of bone marrow monocytic nodules in patients with myelodysplasia: retrospective analysis of 21 cases.
Chen YC; Chou JM; Letendre L; Li CY
Am J Hematol; 2005 Aug; 79(4):329-31. PubMed ID: 16044436
[TBL] [Abstract][Full Text] [Related]
6. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.
Kuo MC; Liang DC; Huang CF; Shih YS; Wu JH; Lin TL; Shih LY
Leukemia; 2009 Aug; 23(8):1426-31. PubMed ID: 19282830
[TBL] [Abstract][Full Text] [Related]
7. Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.
Orazi A; Chiu R; O'Malley DP; Czader M; Allen SL; An C; Vance GH
Mod Pathol; 2006 Dec; 19(12):1536-45. PubMed ID: 17041567
[TBL] [Abstract][Full Text] [Related]
8. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
[TBL] [Abstract][Full Text] [Related]
9. Chronic myelomonocytic leukemia.
Storniolo AM; Moloney WC; Rosenthal DS; Cox C; Bennett JM
Leukemia; 1990 Nov; 4(11):766-70. PubMed ID: 2232890
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.
Mathew RA; Bennett JM; Liu JJ; Komrokji RS; Lancet JE; Naghashpour M; Messina JL; List AF; Moscinski LC; Zhang L
Leuk Res; 2012 Jan; 36(1):72-80. PubMed ID: 21782240
[TBL] [Abstract][Full Text] [Related]
11. Incidence and survival outcomes of chronic myelomonocytic leukemia in the United States.
Guru Murthy GS; Dhakal I; Mehta P
Leuk Lymphoma; 2017 Jul; 58(7):1648-1654. PubMed ID: 27881041
[TBL] [Abstract][Full Text] [Related]
12. Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome.
Patnaik MM; Wassie EA; Padron E; Onida F; Itzykson R; Lasho TL; Kosmider O; Finke CM; Hanson CA; Ketterling RP; Komrokji R; Tefferi A; Solary E
Blood Cancer J; 2015 Jan; 5(1):e270. PubMed ID: 25555161
[TBL] [Abstract][Full Text] [Related]
13. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment in chronic myelomonocytic leukemia (CMML).
Germing U; Kündgen A; Gattermann N
Leuk Lymphoma; 2004 Jul; 45(7):1311-8. PubMed ID: 15359628
[TBL] [Abstract][Full Text] [Related]
16. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
[TBL] [Abstract][Full Text] [Related]
17. Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults.
Zandberg DP; Huang TY; Ke X; Baer MR; Gore SD; Smith SW; Davidoff AJ
Haematologica; 2013 Apr; 98(4):584-90. PubMed ID: 23144192
[TBL] [Abstract][Full Text] [Related]
18. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
[TBL] [Abstract][Full Text] [Related]
19. Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia.
Khan M; Muzzafar T; Kantarjian H; Badar I; Short N; Wang X; Chamoun K; Jain P; DiNardo C; Pemmaraju N; Bose P; Borthakur G; Cortes J; Verstovsek S; Garcia-Manero G; Estrov Z
Ann Hematol; 2018 Jul; 97(7):1183-1191. PubMed ID: 29557496
[TBL] [Abstract][Full Text] [Related]
20. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival.
Sagaster V; Ohler L; Berer A; Kabrna E; Ofner P; Lechner K; Geissler K
Ann Hematol; 2004 Jan; 83(1):9-13. PubMed ID: 13680175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]